Cytokines and tumor metastasis gene variants in oral cancer and precancer in Puerto Rico

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Erdei, Esther ^a,b   Luo, Li ^a,b   Sheng, Huiping ^a,b,c   Maestas, Erika ^a,b   White, Kirsten A M ^a,b   Mackey, Amanda ^a,b,d   Dong, Yan ^a,b,e   Berwick, Marianne ^a,b   Morse, Douglas E ^f  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c SPECTRUM HEALTH   (United States)

^d PRINCETON UNIVERSITY   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; LOGISTIC MODELS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUERTO RICO;

EID: 84894289442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079187     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available: http://globocan.iarc.fr. Accessed 2013 Oct 16.
2. Morse DE, Psoter WJ, Cuadrado L, Torre T, Figueroa N, et al. (2009) A deficit in biopsying potentially premalignant oral lesions in Puerto Rico. Cancer Detect Prev 32: 424-430.
3. Morse DE, Psoter WJ, Cuadrado L, Torre T, Figueroa N J, et al. (2008) Detection of very early oral cancers in Puerto Rico. Am J Public Health 98: 1200-1202. (Pubitemid 351947990)
4. Smith AJ, Humphries SE (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20: 43-59.
5. Hofmann SR, Ettinger R, Zhou YJ, Gadina M, Lipsky P, et al. (2002) Cytokines and their role in lymphoid development, differentiation and homeostasis. Curr Opin Allergy Clin Immunol 2: 495-506. (Pubitemid 36105812)
6. Roitt I (2006) Immunology. New York, NY: C.V. Mosby.
7. Liu YC, Ho HC, Lee MR, Lai KC, Yeh CM, et al. (2012) Early induction of cytokines/cytokine receptors and Cox2, and activation of NF-kappaB in 4-nitroquinoline 1-oxide-induced murine oral cancer model. Toxicol Appl Pharmacol 262: 107-116.
8. Gaur P, Mittal M, Mohanti B, Das S (2011) Functional variants of IL4 and IL6 genes and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Oral Dis 17: 720-726.
9. Gaur P, Mittal M, Mohanti BK, Das SN (2011) Functional genetic variants of TGF-beta1 and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Oral Oncol 47: 1117-1121.
10. Liu CJ, Wong YK, Chang KW, Chang HC, Liu HF, et al. (2005) Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 34: 608-612.
11. Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, et al. (2008) Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 134: 821-832.
12. Kietthubthew S, Wickliffe J, Sriplung H, Ishida T, Chonmaitree T, et al. (2010) Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int J Hyg Environ Health 213: 146-152.
13. Sternberg S (1994) Diagnostic Surgical Pathology, 2nd Edition: Raven Press, NY, NY.
14. Flint PW, Haughey BH, Lund V, Niparko JK, Richardson MA, et al. (2011) Cummings Orolaryngology - Head and Neck Surgery. Philadelphia, PA: Mosby Elsevier.
15. Erdei E, Sheng H, Maestas E, Mackey A, White KA, et al. (2011) Self-reported ethnicity and genetic ancestry in relation to oral cancer and pre-cancer in Puerto Rico. PLoS One 6: e23950.
16. Li L, Psoter WJ, Buxo CJ, Elias A, Cuadrado L, et al. (2011) Smoking and drinking in relation to oral potentially malignant disorders in Puerto Rico: a case-control study. BMC Cancer 11: 324.
17. Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10: 39-49.
18. Tsai MH, Chen WC, Chen HY, Tsai FJ (2004) Urokinase gene 3′-UTR T/C polymorphism is associated with oral cancer. J Clin Lab Anal 18: 276-279.
19. Lescaille G, Menashi S, Cavelier-Balloy B, Khayati F, Quemener C, et al. (2012) EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression. BMC Cancer 12: 115.
20. Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, et al. (2011) Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors. Oncol Rep 26: 1555-1560.
21. Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, et al. (2004) Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202: 14-22. (Pubitemid 38072841)
22. Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS (2007) Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29: 564-572. (Pubitemid 47324773)
23. Yen CY, Chen CH, Chang CH, Tseng HF, Liu SY, et al. (2009) Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers 14: 244-249.
24. Zavras AI, Pitiphat W, Wu T, Cartsos V, Lam A, et al. (2003) Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans. Cancer Res 63: 296-297. (Pubitemid 36157366)
25. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
26. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162-1169. (Pubitemid 37414228)
27. Kingman JF (2000) Origins of the coalescent. 1974-1982. Genetics 156: 1461-1463.
28. Kingman JFC (1982) On the Genealogy of Large Populations. Journal of Applied Probability 19A: 27-43.
29. Mayne ST, Morse DE, Winn DM (2006) Cancers of the Oral Cavity and Pharynx In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. 3rd ed. Oxford: Oxford University Press. pp. 676.
30. Suarez E, Calo WA, Hernandez EY, Diaz EC, Figueroa NR, et al. (2009) Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA. BMC Cancer 9: 129.
31. Cruz GD, Salazar CR, Morse DE (2006) Oral and pharyngeal cancer incidence and mortality among Hispanics, 1996-2002: the need for ethnoregional studies in cancer research. Am J Public Health 96: 2194-2200. (Pubitemid 44865112)
32. Qidwai T, Khan F (2011) Tumour necrosis factor gene polymorphism and disease prevalence. Scand J Immunol 74: 522-547.
33. Serefoglou Z, Yapijakis C, Nkenke E, Vairaktaris E (2008) Genetic association of cytokine DNA polymorphisms with head and neck cancer. Oral Oncol 44: 1093-1099.
34. da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, et al. (2011) Advances and applications of oral cancer basic research. Oral Oncol 47: 783-791.
35. Noutomi T, Itoh M, Toyota H, Takada E, Mizuguchi J (2009) Tumor necrosis factor-related apoptosis-inducing ligand induces apoptotic cell death through c-Jun NH2-terminal kinase activation in squamous cell carcinoma cells. Oncol Rep 22: 1169-1172.
36. Sharma S, Ghosh B, Sharma SK (2008) Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 151: 251-259.
37. Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717-727.
38. Lu CF, Huang CS, Tjiu JW, Chiang CP (2010) Infiltrating macrophage count: a significant predictor for the progression and prognosis of oral squamous cell carcinomas in Taiwan. Head Neck 32: 18-25.
39. De Palma M (2012) Partners in crime: VEGF and IL-4 conscript tumour-promoting macrophages. J Pathol 227: 4-7.
40. Yang JH, Sakamoto H, Xu EC, Lee RT (2000) Biomechanical regulation of human monocyte/macrophage molecular function. Am J Pathol 156: 1797-1804. (Pubitemid 30646717)
41. Tindall EA, Severi G, Hoang HN, Ma CS, Fernandez P, et al. (2010) Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk. Carcinogenesis 31: 1748-1754.
42. Cao ZG, Li CZ (2006) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42: 32-38.
43. Gomes CC, Gomez RS (2008) MicroRNA and oral cancer: future perspectives. Oral Oncol 44: 910-914.
44. Wu BH, Xiong XP, Jia J, Zhang WF (2011) MicroRNAs: new actors in the oral cancer scene. Oral Oncol 47: 314-319.
45. Petersen PE (2005) Strengthening the prevention of oral cancer: the WHO perspective. Community Dent Oral Epidemiol 33: 397-399.